(Q36309636)

13 August 2017

1 reference

title

Treatment for allergic rhinitis and chronic idiopathic urticaria: focus on oral antihistamines (English)

1 reference

13 August 2017

1 reference

1 reference

1 reference

1 reference

Matthew M Morgan

1

1 reference

13 August 2017

David A Khan

series ordinal

2

1 reference

13 August 2017

Robert A Nathan

series ordinal

3

1 reference

13 August 2017

language of work or name

English

0 references

publication date

8 November 2005

1 reference

Annals of Pharmacotherapy

13 August 2017

1 reference

13 August 2017

39

1 reference

13 August 2017

12

1 reference

13 August 2017

2056-2064

1 reference

Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee

13 August 2017

1 reference

Overview of allergic rhinitis

21 January 2018

1 reference

Quality of life in adults and children with allergic rhinitis

21 January 2018

1 reference

Allergic rhinitis: systemic inflammation and implications for management

21 January 2018

1 reference

The extent and nature of disability in different urticarial conditions

21 January 2018

1 reference

The role of histamine in allergic diseases

21 January 2018

1 reference

Neurophysiology of pruritus: cutaneous elicitation of itch

21 January 2018

1 reference

Allergic rhinitis: not purely a histamine-related disease

21 January 2018

1 reference

Allergic rhinitis and its impact on asthma

21 January 2018

1 reference

First do no harm: managing antihistamine impairment in patients with allergic rhinitis.

21 January 2018

1 reference

Electrocardiographic findings in patients with diphenhydramine overdose.

21 January 2018

1 reference

Alkylamine antihistamine toxicity and review of Pediatric Toxicology Registry of the National Association of Medical Examiners. Report 4: Alkylamines

21 January 2018

1 reference

Accidental childhood death from diphenhydramine overdosage.

21 January 2018

1 reference

Acute ketotifen overdosage. A review of present clinical experience

21 January 2018

1 reference

Sedation, cognition, and antihistamines

21 January 2018

1 reference

Antihistamines: models to assess sedative properties, assessment of sedation, safety and other side-effects

21 January 2018

1 reference

Sedation and antihistamines: a review of inter-drug differences using proportional impairment ratios

21 January 2018

1 reference

Histamine H1 receptor occupancy in human brains after single oral doses of histamine H1 antagonists measured by positron emission tomography

21 January 2018

1 reference

Roles of histamine in regulation of arousal and cognition: functional neuroimaging of histamine H1 receptors in human brain

21 January 2018

1 reference

Treatment of hay fever with loratadine--a new non-sedating antihistamine

21 January 2018

1 reference

Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis

21 January 2018

1 reference

24-hour efficacy of once-daily desloratadine therapy in patients with seasonal allergic rhinitis [ISRCTN32042139]

21 January 2018

1 reference

Onset of action and efficacy of terfenadine, astemizole, cetirizine, and loratadine for the relief of symptoms of allergic rhinitis.

21 January 2018

1 reference

Comparative onset of action and symptom relief with cetirizine, loratadine, or placebo in an environmental exposure unit in subjects with seasonal allergic rhinitis: confirmation of a test system

21 January 2018

1 reference

Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis.

21 January 2018

1 reference

Efficacy and tolerability of loratadine versus fexofenadine in the treatment of seasonal allergic rhinitis: a double-blind comparison with crossover treatment of nonresponders.

21 January 2018

1 reference

Effects of fexofenadine and desloratadine on subjective and objective measures of nasal congestion in seasonal allergic rhinitis

21 January 2018

1 reference

Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis

21 January 2018

1 reference

Controlled comparison of the efficacy and safety of cetirizine 10 mg o.d. and fexofenadine 120 mg o.d. in reducing symptoms of seasonal allergic rhinitis

21 January 2018

1 reference

Safety of fexofenadine in children treated for seasonal allergic rhinitis

21 January 2018

1 reference

Fexofenadine is efficacious and safe in children (aged 6-11 years) with seasonal allergic rhinitis

21 January 2018

1 reference

Prospective, long-term safety evaluation of the H1-receptor antagonist cetirizine in very young children with atopic dermatitis. ETAC Study Group. Early Treatment of the Atopic Child.

21 January 2018

1 reference

Evidence of desloratadine syrup efficacy and tolerability in children with pollen-induced allergic rhinitis

21 January 2018

1 reference

Safety of desloratadine syrup in children

21 January 2018

1 reference

Cetirizine and astemizole therapy for chronic idiopathic urticaria: a double-blind, placebo-controlled, comparative trial

21 January 2018

1 reference

Double-blind multicenter study on the efficacy and tolerability of cetirizine compared with oxatomide in chronic idiopathic urticaria in preschool children

21 January 2018

1 reference

Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria.

21 January 2018

1 reference

Comparative efficacy of cetirizine and fexofenadine in the treatment of chronic idiopathic urticaria

21 January 2018

1 reference

The NHS: last act of a Greek tragedy? Government that puts money into redressing inequalities is worthy of support

21 January 2018

1 reference

Safety of second generation antihistamines

21 January 2018

1 reference

Sedative effects of antihistamines: safety, performance, learning, and quality of life

21 January 2018

1 reference

Variations among non-sedating antihistamines: are there real differences?

21 January 2018

1 reference

Transitioning the second-generation antihistamines to over-the-counter status: a cost-effectiveness analysis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1E638

1 reference

13 August 2017

1 reference